Skip to main content
Erschienen in: Pediatric Rheumatology 1/2013

Open Access 01.11.2013 | Meeting abstract

PW02-020 - Colitis revealing mevalonate kinase deficiency

verfasst von: L Michael, J Camille, BM Brigitte

Erschienen in: Pediatric Rheumatology | Sonderheft 1/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Introduction

Hyperimmunoglobulinemia D (HIDS) is the less severe form of mevalonate kinase deficiency (MKD) caused by recessive inherited mutation in the mevalonate kinase gene (MVK). HIDS is characterized by febrile attacks, often associated with transient digestive manifestations, such as abdominal pain, diarrhea and vomiting.

Case report

Here we report for the first time two patients with MKD revealed by a severe neonatal colitis. Both patients had chronic bloody diarrhea and failure to thrive, one patient since the age of one month and the other twelve days. Total parenteral nutrition was required. A marked elevation of acute phase reactants was present, and no evidence of infection was found. In patient 1, ileocolonoscopy revealed an ulcerative colitis at the age of 5 months. Patient 2 suffered from enterocolitis and shock, associated with multiple bowel adhesions at age 5 weeks; the rectosigmoidoscopy showed aphtoid lesions of the sigmoid colon. Pathological findings of colonic biopsies revealed a dense polymorph inflammatory infiltrate associated with deep ulcerations. Febrile attacks occurred 2 months after the onset of digestive symptoms in patient 1, and at onset of disease in patient 2. Genomic sequencing of the MVK gene revealed compound heterozygous mutations in both patients. Anti-interleukin 1 (Anti-IL1) agent (anakinra) produced long-term remission of all digestive features and laboratory parameters.

Discussion

This report emphasizes that MKD may be the cause of severe early-onset inflammatory colitis, and must be considered by physicians, even in the absence of fever, after ruling out infections. Anti-IL1 therapy may result in a dramatic improvement of MKD-related inflammatory bowel disease.

Disclosure of interest

None declared.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Literatur
1.
Zurück zum Zitat van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW: Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008, 87 (6): 301-310. 10.1097/MD.0b013e318190cfb7.CrossRefPubMed van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW: Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008, 87 (6): 301-310. 10.1097/MD.0b013e318190cfb7.CrossRefPubMed
2.
Zurück zum Zitat Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G: Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics. 2011, 128 (1): e152-159. 10.1542/peds.2010-3639.CrossRefPubMed Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G: Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics. 2011, 128 (1): e152-159. 10.1542/peds.2010-3639.CrossRefPubMed
3.
Zurück zum Zitat Touitou I, Lesage S, McDermott M, Cuisset L, Hoffman H, Dode C: Infevers: an evolving mutation database for auto-inflammatory syndromes. Human mutation. 2004, 24 (3): 194-198. 10.1002/humu.20080.CrossRefPubMed Touitou I, Lesage S, McDermott M, Cuisset L, Hoffman H, Dode C: Infevers: an evolving mutation database for auto-inflammatory syndromes. Human mutation. 2004, 24 (3): 194-198. 10.1002/humu.20080.CrossRefPubMed
4.
Zurück zum Zitat Cailliez M, Garaix F, Rousset-Rouviere C, Bruno D, Kone-Paut I, Sarles J: Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. Journal of inherited metabolic disease. 2006, 29 (6): 763-CrossRefPubMed Cailliez M, Garaix F, Rousset-Rouviere C, Bruno D, Kone-Paut I, Sarles J: Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. Journal of inherited metabolic disease. 2006, 29 (6): 763-CrossRefPubMed
5.
Zurück zum Zitat Nimubona L, Laloum D, Rolland MO, Read MH, Guillois B, Duhamel JF: An intestinal obstruction in an eight-month-old child suffering from mevalonic aciduria. Acta paediatrica. 2002, 91 (6): 714-716. 10.1111/j.1651-2227.2002.tb03308.x.CrossRefPubMed Nimubona L, Laloum D, Rolland MO, Read MH, Guillois B, Duhamel JF: An intestinal obstruction in an eight-month-old child suffering from mevalonic aciduria. Acta paediatrica. 2002, 91 (6): 714-716. 10.1111/j.1651-2227.2002.tb03308.x.CrossRefPubMed
6.
Zurück zum Zitat Ruemmele FM, El Khoury MG, Talbotec C, Maurage C, Mougenot JF, Schmitz J: Characteristics of inflammatory bowel disease with onset during the first year of life. Journal of pediatric gastroenterology and nutrition. 2006, 43 (5): 603-609. 10.1097/01.mpg.0000237938.12674.e3.CrossRefPubMed Ruemmele FM, El Khoury MG, Talbotec C, Maurage C, Mougenot JF, Schmitz J: Characteristics of inflammatory bowel disease with onset during the first year of life. Journal of pediatric gastroenterology and nutrition. 2006, 43 (5): 603-609. 10.1097/01.mpg.0000237938.12674.e3.CrossRefPubMed
Metadaten
Titel
PW02-020 - Colitis revealing mevalonate kinase deficiency
verfasst von
L Michael
J Camille
BM Brigitte
Publikationsdatum
01.11.2013
Verlag
BioMed Central
Erschienen in
Pediatric Rheumatology / Ausgabe Sonderheft 1/2013
Elektronische ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A160

Weitere Artikel der Sonderheft 1/2013

Pediatric Rheumatology 1/2013 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.